Cite
MLA Citation
Beverly Moy et al.. “Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update.” Journal of clinical oncology, vol. 39, no. 35, 2021, pp. 3938–3958. http://access.bl.uk/ark:/81055/vdc_100150611153.0x00002e